Literature DB >> 2681899

Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria.

M Nobunaga1, K Yoshioka, M Yasuda, M Shingu.   

Abstract

A differential diagnosis of polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) can be difficult in elderly patients, especially at the prodromal phase of RA. Furthermore, it was felt that there might be a diagnostic criteria for PMR specific to the Japanese. Accordingly, we have retrospectively studied the PMR patients who had come to our hospital, for making a diagnostic criteria. We especially stressed the distinguishing of PMR from RA in elderly patients. The criteria proposed are as follows: 1. Bilateral muscular pain persisting for 2 weeks at least in more than two of the following areas; neck, shoulders or shoulder girdle, upper arms, hips or pelvic girdle and thighs. 2. Normal serum myogenic enzymes. 3. ESR of more than 40 mm/h. 4. No swelling in the hand joints. PMR is defined by the presence of all of the 4 items. The criteria demonstrated a 93.1% sensitivity and 98.3% specificity for PMR.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681899     DOI: 10.2169/internalmedicine1962.28.452

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  12 in total

1.  A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.

Authors:  H A Bird; B F Leeb; C M Montecucco; N Misiuniene; G Nesher; S Pai; C Pease; J Rovensky; B Rozman
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 2.  Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Authors:  Thomas Nothnagl; Burkhard F Leeb
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  [Polymyalgia rheumatica: What is the current status?].

Authors:  M Seitz
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

4.  Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database.

Authors:  Keiko Ogawa; Yoshihiro Kozuka; Hitomi Uno; Kosuke Utsumi; Osamu Noyori; Rumiko Hosoki
Journal:  Clin Drug Investig       Date:  2021-06-10       Impact factor: 2.859

Review 5.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

6.  A disease activity score for polymyalgia rheumatica.

Authors:  B F Leeb; H A Bird
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

7.  The clinical course of polymyalgia rheumatica in Chinese.

Authors:  Wai Ling Li; Yi Lo; Moon Ho Leung; Woon Sing Wong; Mo Yin Mok
Journal:  Clin Rheumatol       Date:  2009-11-15       Impact factor: 2.980

Review 8.  Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review.

Authors:  Annie Huang; Isabel Castrejon
Journal:  Rheumatol Int       Date:  2016-01-14       Impact factor: 2.631

9.  EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).

Authors:  B F Leeb; H A Bird; G Nesher; I Andel; W Hueber; D Logar; C M Montecucco; J Rovensky; J Sautner; M Sonnenblick
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

10.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.